新規登録 | ログイン | FAQ      [?] 

Current Drug Targets - Cardiovascular & Hematological Disorders

最近発刊の雑誌の目次より: Current Drug Targets - Cardiovascular & Hematological Disorders © Bentham Science Publishers
  • Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 431-432.
    by Schoenhagen, Paul, Nissen, E Steven
  • Animal Models of Atherosclerosis Progression: Current Concepts
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 433-440.
    by Mcmahon, , Kritharides, , Lowe,
  • HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 441-453.
    by Kleemann, , Kooistra,
  • Cholesterol Absorption Blockade with Ezetimibe
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 455-462.
    by Toth, P Peter, Davidson, H Michael
  • Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 463-469.
    by Miyazaki, Akira, Kanome, Tomoko, Watanabe, Takuya
  • ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 471-479.
    by Kaul, Sanjay, Shah, K Prediman
  • Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 481-488.
    by Van der Steeg, , El-Harchaoui, , Kuivenhoven, , Kastelein,
  • A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 489-501.
    by Mason,
  • Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 503-512.
    by Allen, , Jandeleit-Dahm,
  • Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 513-525.
    by Gouni-Berthold, , Krone,
  • Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 527-532.
    by Zalewski, , Macphee, , Nelson,
  • Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 533-540.
    by Bruemmer, Dennis, Law, E Ronald
  • Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 541-548.
    by Rouis, Mustapha
  • Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 549-556.
    by Gadde, M Kishore
  • Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 6. (December 2005), pp. 557-564.
    by Villines, C Todd, Taylor, J Allen
  • Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 5. (October 2005), pp. 355-375.
    by Antonis S Manolis, Stylianos Tzeis, Kostas Triantafyllou, John Michaelidis, Ioannis Pyrros, Nikolaos Sakellaris, Athanasios Kranidis, Helen Melita
  • Role of PPAR-gamma Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 5. (October 2005), pp. 377-386.
    by Rupal Dumasia, Kim A Eagle, Eva Kline-Rogers, Niquole May, Leslie Cho, Debabrata Mukherjee
  • The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 5. (October 2005), pp. 387-403.
    by Polychronis Dilaveris, Georgios Giannopoulos, Andreas Synetos, Christodoulos Stefanadis
  • Will this be the End of the Anticoagulation Clinic for Patients with Atrial Fibrillation?
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 5. (October 2005), pp. 405-408.
    by Andrew R Mitchell
  • Drug Therapy in Brugada Syndrome
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 5. (October 2005), pp. 409-417.
    by Manlio F Marquez, Gabriel Salica, Antonio G Hermosillo, Gustavo Pastelin, Manuel Cardenas
  • An Old Drug with a New Purpose: Cardiovascular Actions of Acetaminophen (Paracetamol)
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 5. (October 2005), pp. 419-429.
    by Norell M Spiler, Tyler H Rork, Gary F Merrill
  • Endothelial Progenitor Cells as Potential Drug Targets
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 4. (August 2005), pp. 277-286.
    by T Thum, J Bauersachs
  • Endothelin Receptor Antagonists: Another Potential Alternative for Cardiovascular Diseases
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 4. (August 2005), pp. 287-301.
    by Tostes, MN Muscara
  • Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 4. (August 2005), pp. 303-311.
    by JA Paramo, JA Rodriguez, O Beloqui, J Orbe
  • Drug Eluting Stents in Interventional Cardiology - Current Evidence and Emerging Uses
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 4. (August 2005), pp. 313-321.
    by N Swanson, AH Gershlick
  • The Na+/H+ Exchanger: A Target for Cardiac Therapeutic Intervention
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 4. (August 2005), pp. 323-335.
    by M Karmazyn, M Sawyer, L Fliegel
  • Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 4. (August 2005), pp. 337-343.
    by G Barbaro
  • Imaging of Visceral Adipose Tissue: An Emerging Diagnostic Tool and Therapeutic Target
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 4. (August 2005), pp. 345-353.
    by G Iacobellis
  • Editorial Hot Topic:Fighting Antibody Mediated Rejection (Guest Editor: Robert Zhong )
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 3. (June 2005), pp. 197-198.
    by Robert Zhong
  • Pathological Features of Antibody-Mediated Rejection
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 3. (June 2005), pp. 199-214.
    by Akira Shimizu, Robert B Colvin
  • Modulating Alloimmune Responses with Plasmapheresis and IVIG
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 3. (June 2005), pp. 215-222.
    by Daniel S Warren, Christopher E Simpkins, Matthew Cooper, Robert A Montgomery
  • Targeting Antibody-Mediated Rejection in the Setting of ABOIncompatible Infant Heart Transplantation: Graft Accommodation vs. B Cell Tolerance
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 3. (June 2005), pp. 223-232.
    by Lori J West
  • Antibody Mediated Rejection in Pig-To-Nonhuman Primate Xenotransplantation Models
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 3. (June 2005), pp. 233-253.
    by Emanuele Cozzi, Michela Severo, Erika Bosio, Federica Besenzon, Ermanno Ancona
  • Beyond Antibody-Mediated Rejection: Hyperacute Lung Rejection as a Paradigm for Dysregulated Inflammation
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 3. (June 2005), pp. 255-269.
    by Bao H Nguyen, Egon Zwets, Carsten Schroeder, RN Pierson, Agnes M Azimzadeh
  • B Cell Tolerance: Lessons from Transplantation
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 3. (June 2005), pp. 271-275.
    by Marilia Cascalho
  • Editorial Statins: Hot Topic: Statins: Effects Beyond Cholesterol Lowering (Guest Editor: Garry X. Shen)
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 111-113.
    by Garry X Shen
  • Statins and Thrombin
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 115-120.
    by J Fenton, D Brezniak, F Ofosu, G Shen, J Jacobson, J Garcia
  • Mechanisms for Antiplatelet Action of Statins
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 121-126.
    by Luca Puccetti, Anna L Pasqui, Alberto Auteri, Fulvio Bruni
  • Cholesterol-independent Effects of Statins in Inflammation, Immunomodulation and Atherosclerosis
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 127-134.
    by Claire Arnaud, Niels R Veillard, Francois Mach
  • Statin-induced Vascular Smooth Muscle Cell Apoptosis: A Possible Role in the Prevention of Restenosis?
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 135-144.
    by Wolfgang Erl
  • Three's Company: Regulation of Cell Fate by Statins
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 145-163.
    by Joannis E Vamvakopoulos
  • The Role of Statins in Oxidative Stress and Cardiovascular Disease
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 165-175.
    by Dominic S Ng
  • Biological Properties of Baicalein in Cardiovascular System
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 177-184.
    by Yu Huang, Suk-Ying Tsang, Xiaoqiang Yao, Zhen-Yu Chen
  • Common Therapeutic Strategies in the Management of Sexual Dysfunction and Cardiovascular Disease
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 2. (April 2005), pp. 185-195.
    by T Hale, J Hannan, J Heaton, M Adams
  • Editorial
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 1. (February 2005), 1.
    by Alexandra Lucas
  • Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 1. (February 2005), 3.
    by Sophia Adamia, Christopher A Maxwell, Linda M Pilarski
  • The Future of Angiotensin II Inhibition in Cardiovascular Medicine
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 1. (February 2005), 15.
    by Pascal Meier, Marc Maillard, Michel Burnier
  • ABC Transporters and Sterol Absorption
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 1. (February 2005), 31.
    by Robert A Hegele, John F Robinson
  • Cancer Metastasis: Characterization and Identification of the Behavior of Metastatic Tumor Cells and the Cell Adhesion Molecules, including Carbohydrates
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 1. (February 2005), 39.
    by Takanori Kawaguchi
  • Nitric Oxide and its Antithrombotic Action in the Cardiovascular System
    Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, No. 1. (February 2005), 65.
    by Reichenbach Gustavo, Momi Stefania, Gresele Paolo
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/ben-cdtchd

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.